Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, 92093, USA.
Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, University of Texas Austin, Austin, TX, 78712, USA.
ChemMedChem. 2019 Jul 3;14(13):1271-1282. doi: 10.1002/cmdc.201900172. Epub 2019 May 24.
New Delhi metallo-β-lactamase-1 (NDM-1) poses an immediate threat to our most effective and widely prescribed drugs, the β-lactam-containing class of antibiotics. There are no clinically relevant inhibitors to combat NDM-1, despite significant efforts toward their development. Inhibitors that use a carboxylic acid motif for binding the Zn ions in the active site of NDM-1 make up a large portion of the >500 inhibitors reported to date. New and structurally diverse scaffolds for inhibitor development are needed urgently. Herein we report the isosteric replacement of one carboxylate group of dipicolinic acid (DPA) to obtain DPA isosteres with good inhibitory activity against NDM-1 (and related metallo-β-lactamases, IMP-1 and VIM-2). It was determined that the choice of carboxylate isostere influences both the potency of NDM-1 inhibition and the mechanism of action. Additionally, we show that an isostere with a metal-stripping mechanism can be re-engineered into an inhibitor that favors ternary complex formation. This work provides a roadmap for future isosteric replacement of routinely used metal binding motifs (i.e., carboxylic acids) for the generation of new entities in NDM-1 inhibitor design and development.
新德里金属-β-内酰胺酶 1(NDM-1)对我们最有效和广泛使用的β-内酰胺类抗生素构成了直接威胁。尽管在开发方面做出了巨大努力,但仍没有针对 NDM-1 的临床相关抑制剂。用于结合 NDM-1 活性部位 Zn 离子的羧酸基 motif 的抑制剂构成了迄今为止报道的超过 500 种抑制剂的大部分。迫切需要用于抑制剂开发的新的和结构多样化的支架。在此,我们报告了二吡啶甲酸(DPA)的一个羧酸盐基团的等排体替换,以获得对 NDM-1(和相关的金属-β-内酰胺酶,IMP-1 和 VIM-2)具有良好抑制活性的 DPA 等排体。结果表明,羧酸盐等排体的选择会影响 NDM-1 抑制的效力和作用机制。此外,我们还表明,可以对具有脱金属作用机制的等排体进行重新设计,使其有利于三元复合物的形成。这项工作为 NDM-1 抑制剂设计和开发中的新型实体的生成提供了常规金属结合基序(即羧酸)的未来等排体替换的路线图。